Genetic Embryo Testing (PGT): When It Is Needed and What It Reveals

Genetic embryo testing is an essential component of modern reproductive technologies and is widely used in assisted conception programs. When infertility has a complex origin, accurate assessment of embryo quality before transfer becomes critically important. The use of PGT in IVF allows potential risks to be identified in advance and increases the likelihood of successful implantation. This approach is especially relevant for couples seeking a predictable outcome and the birth of a healthy child.

Preimplantation assessment is performed as part of comprehensive medical care and complements standard infertility treatment. For many patients, it becomes a tool that helps reduce the number of unsuccessful attempts and emotional stress. That is why genetic control at the embryonic stage is now regarded as a key element of modern reproductive medicine.

Preimplantation genetic testing is a method of evaluating an embryo’s genetic material before it is transferred to the uterus. The procedure is carried out at the blastocyst stage and does not interfere with further embryo development. The obtained data are integrated into the overall IVF program and used for clinical decision-making. Embryo genetic testing is based on high-precision laboratory techniques that ensure reliable results.

Before transfer, specialists perform a comprehensive analysis that allows each chromosome to be assessed and serious abnormalities to be excluded. This preimplantation approach makes it possible to select the embryo most suitable for implantation. In clinical practice, the term PGD is historically associated with earlier diagnostic methods and is now considered part of the broader PGT concept.

The diagnostic capabilities of PGT cover a wide range of changes that affect implantation and pregnancy progression. The test can identify embryo aneuploidy, where the normal number of chromosomes is altered. Structural chromosomal abnormalities associated with IVF can also be detected. Such deviations often lead to developmental arrest or early pregnancy loss.

Genetically abnormal embryos are frequently unable to develop properly even under ideal conditions. Therefore, timely identification of these changes plays a crucial role in transfer planning. PGT makes it possible to assess the contribution of individual genes to embryo viability and reduce the risk of complications.

There are clinical situations in which genetic testing provides the greatest benefit. The decision to use it is made individually, taking into account the couple’s medical history and previous attempts. Indications for PGT are based on a combination of factors influencing cycle outcome. Particular attention is given to age-related genetic risks in IVF, which are directly associated with a higher probability of chromosomal errors.

The main situations in which testing is recommended include:

Each of these factors requires careful evaluation by a specialist. For patients with a complicated reproductive history, testing becomes not an optional add-on but an essential part of treatment strategy.

Selecting embryos with a normal genetic profile directly improves IVF outcomes with PGT. Excluding non-viable embryos reduces the risk of negative results and decreases the number of transfers without pregnancy. This optimizes the reproductive process and reduces physical stress on the patient. As a result, the chances of a healthy pregnancy through IVF increase.

In addition, the likelihood of early miscarriage is reduced. More accurate screening allows physicians to better predict outcomes and adjust treatment tactics. For patients, this means a more controlled and predictable path to parenthood.

At Dr. Steinke Clinic, modern PGT methods based on high-precision molecular diagnostics and advanced laboratory solutions are used. Each applied technology undergoes strict quality control and complies with international standards. This ensures reliable data and enables personalized transfer planning. An individualized IVF approach is achieved through comprehensive clinical evaluation and close collaboration between specialists.

The clinic’s work is guided by the following principles:

This approach allows each clinical case to be treated as unique. Comprehensive assessment, precise risk identification, and focus on the final outcome make Dr. Steinke Clinic’s practice effective and safe for patients.